You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Moffitt study shows new immune boost could expand access to cancer immunotherapy
- 2. Research status and frontiers in liver cancer immunotherapy: a bibliometric perspective on highly cited literature
- 3. Prostate cancer: A new at-home saliva test beats blood test
- 4. Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
- 5. Case Report: Abiraterone in brain metastases from prostate cancer
- 6. Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
- 7. Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications
- 8. KSQ Therapeutics Announces First Patient Dosed in Phase 1/2 Study for KSQ-004EX, a CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy
- 9. Newfound role for cancer gene could improve key drug class
- 10. 'Sugar' signatures help identify and classify pancreatic cancer cell subtypes
Last updated at 12:55 GMT
Hot News Makers
Health/Pharma Companies
-
1848.40
-
1757.24
-
1347.03
-
1186.75
-
741.87
-
620.06
-
617.26
-
555.47
-
494.16
-
457.14
Drugs, Treatments, Trials
-
1157.61
-
294.55
-
193.81
-
180.88
-
150.31
-
109.85
-
109.58
-
90.70
-
78.57
-
73.23
Last updated at 12:10 GMT
